期刊文献+

健心颗粒干预左室射血分数正常的心衰临床研究 被引量:9

Clinical Observation on Jianxin Granules for Treatment of Heart Failure with Normal LVEF
下载PDF
导出
摘要 目的探讨健心颗粒对左室射血分数正常的心衰(HFNEF)患者心功能和中医证候的影响。方法将60例气虚血瘀、水饮内停证HFNEF患者随机分为治疗组和对照组,治疗组在常规西药基础上加服健心颗粒,两组均连续服药12周,比较两组临床症状、血浆脑钠肽(BNP)、左室舒张末期内径(LVEDd)、舒张早期血流峰速度(E)/舒张晚期血流峰速度(A)和6 min步行距离(6MWT)以及中医证候积分改善情况。结果治疗后,两组临床症状和中医证候积分均显著改善,血浆BNP以及LVEDd降低,E/A、6MWT水平提高,且治疗组优于对照组(P<0.01)。结论在常规西药基础上加用健心颗粒可以改善气虚血瘀、水饮内停证HFNEF患者心功能,改善临床症状。 Objective To observe the effect of Jianxin granules(JXG) on cardiac function and traditional Chinese medicine(TCM) syndrome in heart failure with normal left ventricular(LV) ejection fraction(HFNEF).Methods Sixty patients with syndrome of qi deficiency,blood stasis and accumulation of excessive fluid in the body were randomly divided into into two groups:Control group(n=30) treated with the routine treatment and treatment group(n=30) treated with JXG and routine treatment.The clinical symptoms,TCM syndrome,plasma brain natriuretic peptide(BNP) level,E/A ratio and left ventricular end-diastolic dimension(LVEDd),6 minute walk test(6MWT) were compared between the two groups.Results Clinical symptoms and TCM syndrome were improved significantly in the two groups.BNP level and LVEDd were decreased.The E/A ratio and 6MWT were improved.All of them in treatment group were better than that in control group.Conclusion Routine treatment of western medicine combined with Jianxin Granules could further improve cardiac function and clinical symptoms in patient with HFNEF and syndrome of qi deficiency,blood stasis and accumulation of excessive fluid in the body.
出处 《中西医结合心脑血管病杂志》 2012年第10期1155-1157,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 心力衰竭 左室射血分数 健心颗粒 heart failure left ventricular ejection fraction Jianxin Granules
  • 相关文献

参考文献5

二级参考文献60

  • 1猪苓的抗醛甾酮利尿作用成分[J].国外医学(中医中药分册),2005,27(2):120-121. 被引量:2
  • 2中华人民共和国卫生部颁布.中药新药临床研究指导原则.,1993.57~60.
  • 3Groenning BA,Nilsson JC,Sondergaard L,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.Eur J Heart Fail,2001,3(6):699~708.
  • 4Peter MK.Seigo I. Apoptosis and heart failure: A critical review of the literature[J].Circ Res.2000,86 : 1107 - 1113.
  • 5Sumanth D. Prabhu. Nitric oxide protects against pathological ven tricular remod ling:Reconsidoration of the role of NO in the failing heart[J]. Circt iation Research,94:1155.
  • 6Bengoechea - Alonso MT, Pelacho B,Oses - Prieto JA ,et al. Regu lation of NF - kappa B Activation by protein phosphatase. 2B and NO,via protein kinase A activity,inhuman monoeytes [J].Nitric Oxide,2003,8(1) :65-74.
  • 7Riiter O, Schuh K, Brede M. AT2 receptor activation regulates myocardial eNOS expression via the calcineurin - NF , AT pathway [J].Faseb J,2003,17(2) :283 285.
  • 8Damy T, Ratajczak P, Robidel E, et al. Up - regulation of cardiac nitric oxide synthase 1 - derived nitric oxide aftermyocardial infarc tion in senescent rats[J].Faseb J. 2003,17(13) : 1934 - 1936.
  • 9Saito T. Hu F, Tayara L, st al. Inhibition of NOS2 prevents cardiac dysfunction in myocardial infarction and congestive heart failure [J].Am J Physiol Hcart Circ Physiol,2002,283(1) : 339 - 345.
  • 10Jones SP. Greer J J, Van Haperen R, et al. Endothelial nitric oxide synthaseoverexpression attenuates congestive heart failure in mice [J]. Proc Natl Acad Sci USA,2003,100:4891 -4896.

共引文献46

同被引文献137

  • 1李瑞杰.美国心脏病学会和美国心脏协会2005成人慢性心力衰竭诊断与治疗指南(连载1)[J].临床荟萃,2006,21(11):761-764. 被引量:36
  • 2张艳,方素清,姜凯,宋婷婷.慢性心衰气虚血瘀证大鼠模型的研究初探[J].中国中医药信息杂志,2006,13(8):14-15. 被引量:28
  • 3吴泰相,李幼平,卞兆祥,李廷谦,李静,Simon Dagenais,David Moher,无.中医药临床随机对照试验报告规范(征求意见稿)[J].中国循证医学杂志,2007,7(8):601-605. 被引量:124
  • 4Owan TE, Hodge DO, Herges RM,et al. Trends in prevalenceand outcome of heart failure with preserved ejection fraction[J].N Engl J Med,2006,355:251 - 259.
  • 5Gottdiener JS, McClelland RL,Marshall R,et al. Outcome ofcongestive heart failure in elderly persons: influence of left ven-tricular systolic function [J]. Ann Intern Med, 2002,137: 631 -639.
  • 6Bronzwaer JG,Paulus WJ. Matrix, cytoskeleton,or myofila-ments: Which one to blame for diastolic left ventricular dysfunc-tion [J]. Prog Cardiovasc Dis,2005,47:276 - 284.
  • 7Yamamoto K,Masuyama T,Sakata Y,et al. Myocardial stiffnessis determined by ventricular fibrosis but not by compensatory orexcessive hypertrophy in hypertensive heart [ J]. CardiovascRes ,2002,55:76-82.
  • 8Paulus WJ. Beneficial effects of nitric oxide on cardiac diastolicfunction: “The flip side of the coin” [J]. Heart Fail Rev,2000,5:337-344.
  • 9Lazich UBakris GL. Endothelin antagonism in patients with re-sistant hypertension and hypertension nephropathy[J]. ContribNephrol,2011,172 : 223-234.
  • 10Capozzi G,Santoro G. Patent ductus arteriosus : Patho - physiol-ogy, hemodynamic effects and clinical complications[J]. J Ma-te rn Fetal Neonatal Med.2011,24:15- 16.

引证文献9

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部